- Home
- PTGX vs SGHC Comparison
PTGX vs SGHC Comparison
Compare PTGX & SGHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PTGX | SGHC |
|---|---|---|
| Founded | 2006 | 2020 |
| Country | United States | Guernsey |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 5.8B |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | PTGX | SGHC |
|---|---|---|
| Price | $88.37 | $11.95 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 8 |
| Target Price | ★ $90.56 | $16.00 |
| AVG Volume (30 Days) | 1.1M | ★ 2.5M |
| Earning Date | 11-06-2025 | 11-03-2025 |
| Dividend Yield | N/A | ★ 1.32% |
| EPS Growth | N/A | ★ 4925.62 |
| EPS | ★ 0.72 | 0.45 |
| Revenue | $209,217,000.00 | ★ $2,342,912,011.00 |
| Revenue This Year | N/A | $27.17 |
| Revenue Next Year | $296.47 | $10.88 |
| P/E Ratio | $121.37 | ★ $26.67 |
| Revenue Growth | N/A | ★ 34.94 |
| 52 Week Low | $33.70 | $5.45 |
| 52 Week High | $96.54 | $14.38 |
Technical Indicators
Market Signals| Indicator | PTGX | SGHC |
|---|---|---|
| Relative Strength Index (RSI) | 51.51 | 55.43 |
| Support Level | $84.11 | $11.21 |
| Resistance Level | $96.54 | $12.06 |
| Average True Range (ATR) | 3.37 | 0.43 |
| MACD | -0.90 | 0.11 |
| Stochastic Oscillator | 28.80 | 86.86 |
Price Performance
Historical ComparisonAbout PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About SGHC Super Group (SGHC) Limited
Super Group (SGHC) Ltd is a holding company that operates online sports betting and gaming businesses. The company's reportable segments are Betway, Spin, and Other. A majority of its revenue is generated from the Betway segment, which is a single-brand online sports betting and casino offering with licenses to operate throughout Europe, the Americas, and Africa. Spin is the company's multi-brand online casino offering, having a diverse portfolio of casino brands such as Jackpot City, Spin Casino, Dream Bingo, Mirror Bingo, etc., designed to be culturally relevant globally while aiming to offer a wide range of casino products. Geographically, the company generates maximum revenue from Africa and Middle East, followed by North America, Europe, Asia-Pacific, and South/Latin America.